• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KNSTRN 通过激活膀胱癌中的 AKT 促进肿瘤发生和吉西他滨耐药性。

KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Oncogene. 2021 Mar;40(9):1595-1608. doi: 10.1038/s41388-020-01634-z. Epub 2021 Jan 15.

DOI:10.1038/s41388-020-01634-z
PMID:33452459
Abstract

KNSTRN is a component of the mitotic spindle, which was rarely investigated in tumorigenesis. AKT plays an essential role in tumorigenesis by modulating the phosphorylation of various substrates. The activation of AKT is regulated by PTEN and PIP. Here, we prove KNSTRN is positively correlated with malignancy of bladder cancer and KNSTRN activates AKT phosphorylation at Thr308 and Ser473. More importantly, our study reveals that both KNSTRN and PTEN interact with PH domain of AKT at cell membrane. The amount of KNSTRN interacted with AKT is negatively related to PTEN. Furthermore, PIP pull-down assay proves that KNSTRN promoted AKT movement to PIP. These data suggest KNSTRN may activate AKT phosphorylation by promoting AKT movement to PIP and alleviating PTEN suppression. Based on the activation of AKT phosphorylation, our study demonstrates that KNSTRN promotes bladder cancer metastasis and gemcitabine resistance in vitro and in vivo. Meanwhile, the effect of KNSTRN on tumorigenesis and gemcitabine resistance could be restored by AKT specific inhibitor MK2206 or AKT overexpression. In conclusion, we identify an oncogene KNSTRN that promotes tumorigenesis and gemcitabine resistance by activating AKT phosphorylation and may serve as a therapeutic target in bladder cancer.

摘要

KNSTRN 是有丝分裂纺锤体的一个组成部分,在肿瘤发生中很少被研究。AKT 通过调节各种底物的磷酸化在肿瘤发生中发挥重要作用。AKT 的激活受 PTEN 和 PIP 调节。在这里,我们证明 KNSTRN 与膀胱癌的恶性程度呈正相关,并且 KNSTRN 激活 AKT 在 Thr308 和 Ser473 的磷酸化。更重要的是,我们的研究揭示了 KNSTRN 和 PTEN 都在细胞膜上与 AKT 的 PH 结构域相互作用。与 AKT 相互作用的 KNSTRN 量与 PTEN 呈负相关。此外,PIP 下拉测定证明 KNSTRN 促进 AKT 向 PIP 的运动。这些数据表明,KNSTRN 可能通过促进 AKT 向 PIP 的运动并减轻 PTEN 的抑制来激活 AKT 磷酸化。基于 AKT 磷酸化的激活,我们的研究表明 KNSTRN 促进膀胱癌的体外和体内转移和吉西他滨耐药。同时,KNSTRN 对肿瘤发生和吉西他滨耐药的作用可以通过 AKT 特异性抑制剂 MK2206 或 AKT 过表达来恢复。总之,我们鉴定了一种癌基因 KNSTRN,它通过激活 AKT 磷酸化促进肿瘤发生和吉西他滨耐药,并且可能成为膀胱癌的治疗靶点。

相似文献

1
KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.KNSTRN 通过激活膀胱癌中的 AKT 促进肿瘤发生和吉西他滨耐药性。
Oncogene. 2021 Mar;40(9):1595-1608. doi: 10.1038/s41388-020-01634-z. Epub 2021 Jan 15.
2
UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT.UPP1 通过 AKT 促进膀胱癌的进展和吉西他滨耐药性。
Int J Biol Sci. 2024 Jan 27;20(4):1389-1409. doi: 10.7150/ijbs.83774. eCollection 2024.
3
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.长链非编码 RNA UCA1 通过调控 CREB 介导的 miR-196a-5p 促进膀胱癌顺铂/吉西他滨耐药。
Cancer Lett. 2016 Nov 1;382(1):64-76. doi: 10.1016/j.canlet.2016.08.015. Epub 2016 Aug 31.
4
KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.KNSTRN 是一种预后生物标志物,与乳腺癌中的免疫浸润相关,并促进细胞周期和增殖。
Biochem Genet. 2024 Oct;62(5):3709-3739. doi: 10.1007/s10528-023-10615-2. Epub 2024 Jan 10.
5
HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy.HEATR1负向调控Akt以帮助胰腺癌细胞对化疗敏感。
Cancer Res. 2016 Feb 1;76(3):572-81. doi: 10.1158/0008-5472.CAN-15-0671. Epub 2015 Dec 16.
6
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.吉西他滨与培美曲塞的体外协同细胞毒性及膀胱癌患者对吉西他滨反应的药物遗传学评估
Br J Cancer. 2006 Aug 7;95(3):289-97. doi: 10.1038/sj.bjc.6603242. Epub 2006 Jul 25.
7
miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.miRNA-93-5p 通过靶向 PTEN 介导的 PI3K/Akt 信号通路促进胰腺癌细胞对吉西他滨的耐药性。
Ann Clin Lab Sci. 2021 May;51(3):310-320.
8
Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.橄榄油厂废水通过下调 Akt/mTOR 信号通路抑制顺铂和吉西他滨耐药膀胱癌细胞的体外生长和增殖。
Nutrients. 2022 Jan 15;14(2):369. doi: 10.3390/nu14020369.
9
Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.小檗碱通过抑制 PI3K/Akt 通路使 Rad51 表达下调从而增强吉西他滨诱导的膀胱癌细胞毒性。
Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8244. Epub 2021 Dec 22.
10
CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.CYLD下调Livin并协同提高吉西他滨化疗敏感性,降低膀胱癌的迁移/侵袭潜能:其作用与自噬相关。
Tumour Biol. 2016 Sep;37(9):12731-12742. doi: 10.1007/s13277-016-5157-0. Epub 2016 Jul 22.

引用本文的文献

1
Long non-coding RNA MINCR silencing contributes to suppressed gemcitabine resistance in bladder cancer by blocking the ZEB1/PHGDH axis through microRNA-876-5p up-regulation.长链非编码RNA MINCR沉默通过上调微小RNA-876-5p阻断ZEB1/PHGDH轴,从而有助于抑制膀胱癌对吉西他滨的耐药性。
J Mol Histol. 2025 Jul 9;56(4):220. doi: 10.1007/s10735-025-10510-7.
2
Everolimus in pituitary tumor: a review of preclinical and clinical evidence.依维莫司治疗垂体瘤:临床前及临床证据综述
Front Endocrinol (Lausanne). 2024 Dec 16;15:1456922. doi: 10.3389/fendo.2024.1456922. eCollection 2024.
3
Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions.

本文引用的文献

1
Analysis of gene co‑expression network reveals prognostic significance of CNFN in patients with head and neck cancer.分析基因共表达网络揭示 CNFN 在头颈部癌症患者中的预后意义。
Oncol Rep. 2019 Apr;41(4):2168-2180. doi: 10.3892/or.2019.7019. Epub 2019 Feb 18.
2
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
探索内质网应激在泌尿系统癌症中的双重作用:对肿瘤进展和细胞死亡相互作用的影响
J Cell Commun Signal. 2024 Nov 3;18(4):e12054. doi: 10.1002/ccs3.12054. eCollection 2024 Dec.
4
Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancer.膀胱癌中细胞周期进展相关风险模型的预后意义及免疫格局
Discov Oncol. 2024 May 12;15(1):160. doi: 10.1007/s12672-024-01008-x.
5
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.环状KDM1A通过吸附miR-889-3p/CPEB3并稳定p53 mRNA来抑制膀胱癌进展。
iScience. 2024 Mar 29;27(4):109624. doi: 10.1016/j.isci.2024.109624. eCollection 2024 Apr 19.
6
UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT.UPP1 通过 AKT 促进膀胱癌的进展和吉西他滨耐药性。
Int J Biol Sci. 2024 Jan 27;20(4):1389-1409. doi: 10.7150/ijbs.83774. eCollection 2024.
7
PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating DDB1 in bladder cancer cells.PRPF19通过调控膀胱癌细胞中的DDB1在DNA损伤修复和吉西他滨敏感性中发挥作用。
Cytotechnology. 2024 Feb;76(1):85-96. doi: 10.1007/s10616-023-00599-7. Epub 2023 Oct 5.
8
NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma.NamiRNA介导的KNSTRN高表达与肝细胞癌的不良预后和免疫浸润相关。
Contemp Oncol (Pozn). 2023;27(3):163-175. doi: 10.5114/wo.2023.133507. Epub 2023 Dec 6.
9
KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.KNSTRN 是一种预后生物标志物,与乳腺癌中的免疫浸润相关,并促进细胞周期和增殖。
Biochem Genet. 2024 Oct;62(5):3709-3739. doi: 10.1007/s10528-023-10615-2. Epub 2024 Jan 10.
10
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.DLGAP5 通过 USP11 稳定 E2F1 促进膀胱癌的增殖和转移。
Oncogene. 2024 Feb;43(8):594-607. doi: 10.1038/s41388-023-02932-y. Epub 2024 Jan 5.